IMU 4.00% 4.8¢ imugene limited

Ann: First patient dosed in Phase 1 bile tract cancer trial, page-7

  1. 280 Posts.
    lightbulb Created with Sketch. 151
    Last weeks presentation indicated MAST trial cohort 3 - 6 3x10,8 IT had been cleared (highlighted in green) yet this release still shows as work in progress (highlighted in yellow).
    Maybe a timing issue around preparation of these releases?

    - WE.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.